Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
S.4426, Promising Pathway Act 2.0 (118th Congress)
FDA modernization H.R.1262 - Give Kids a Chance Act Trump administration impact on staffing at HHS and FDA Newborn screening Inflation Reduction Act (IRA) H.R.946 - ORPHAN Cures Act H.R. 1414 - Cameron's Law H.R.1532 - Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1492 - Ensuring Pathways to Innovative Cures (EPIC) Act
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AZURITY PHARMACEUTICALS, INC. via THE KPM GROUP DC LLC
2026 · third_quarter · Q3
Colorectal cancer bowel prep
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRAXIS PRECISION MEDICINES via THE KPM GROUP DC LLC
2026 · third_quarter · Q3
Source: Senate LDA
| OPIANT PHARMACEUTICALS |
| 5 |
| 2019–2020 |
| OVID THERAPEUTICS | 5 | 2019–2021 |
| REZOLUTE | 5 | 2025–2026 |
| MANNKIND CORPORATION | 4 | 2020–2021 |
| AZURITY PHARMACEUTICALS, INC. | 3 | 2026 |
| CHIESI USA INC | 3 | 2020–2021 |
| GRITSTONE ONCOLOGY | 3 | 2020–2021 |
| JEREMY LEVIN | 3 | 2023 |
| ATAI LIFE SCIENCES N.V. | 2 | 2021 |
| INOZYME PHARMA | 2 | 2025 |
| MAHZI THERAPEUTICS | 2 | 2026 |
| ORPHAZYME US, INC. | 2 | 2020–2021 |
| PHARMAESSENTIA CORPORATION | 2 | 2021 |
| PRAXIS PRECISION MEDICINES | 2 | 2026 |
| SANGAMO THERAPEUTICS, INC | 2 | 2020–2021 |
| SUMMIT THERAPEUTICS PLC | 2 | 2020 |
| THE BRAIN DONOR PROJECT | 2 | 2021 |
| ACCELERON PHARMA | 1 | 2021 |
| BIOAGILYTIX LABS, LLC | 1 | 2021 |
| COGNOA, INC. | 1 | 2021 |
| FULCRUM THERAPEUTICS, INC. | 1 | 2024 |
| GENSIGHT BIOLOGICS S.A. | 1 | 2023 |
| NATIONAL BOARD FOR CERTIFIED COUNSELORS, INC. AND AFFILIATES | 1 | 2021 |
| RELMADA THERAPEUTICS, INC. | 1 | 2021 |
H.R.1262/S.932 - Give Kids a Chance Act H.R.946 - ORPHAN Cures Act H.R. 1414 - Cameron's Law H.R.1532/S.822 - Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1492 - Ensuring Pathways to Innovative Cures (EPIC) Act
H.R.1262/S.932 - Give Kids a Chance Act H.R.946 - ORPHAN Cures Act H.R. 1414 - Cameron's Law H.R.1532/S.822 - Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1492 - Ensuring Pathways to Innovative Cures (EPIC) Act
FDA modernization H.R.1262 - Give Kids a Chance Act Trump administration impact on staffing at HHS and FDA Newborn screening Inflation Reduction Act (IRA) H.R.946 - ORPHAN Cures Act H.R. 1414 - Cameron's Law H.R.1532 - Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1492 - Ensuring Pathways to Innovative Cures (EPIC) Act
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: INOZYME PHARMA · Firm: THE KPM GROUP DC LLC
FDA modernization H.R.1262 - Give Kids a Chance Act Trump administration impact on staffing at HHS and FDA Newborn screening Inflation Reduction Act (IRA) H.R.946 - ORPHAN Cures Act H.R. 1414 - Cameron's Law H.R.1532 - Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1492 - Ensuring Pathways to Innovative Cures (EPIC) Act
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: INOZYME PHARMA · Firm: THE KPM GROUP DC LLC
H.R.1262/S.932 - Give Kids a Chance Act H.R.946 - ORPHAN Cures Act H.R. 1414 - Cameron's Law H.R.1532/S.822 - Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1492 - Ensuring Pathways to Innovative Cures (EPIC) Act
FDA modernization H.R.1262 - Give Kids a Chance Act Trump administration impact on staffing at HHS and FDA Newborn screening Inflation Reduction Act (IRA) H.R.946 - ORPHAN Cures Act H.R. 1414 - Cameron's Law H.R.1532 - Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1492 - Ensuring Pathways to Innovative Cures (EPIC) Act
H.R.1262/S.932 - Give Kids a Chance Act H.R.946 - ORPHAN Cures Act H.R. 1414 - Cameron's Law H.R.1532/S.822 - Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1492 - Ensuring Pathways to Innovative Cures (EPIC) Act
FDA modernization H.R.1262 - Give Kids a Chance Act Trump administration impact on staffing at HHS and FDA Newborn screening Inflation Reduction Act (IRA) H.R.946 - ORPHAN Cures Act H.R. 1414 - Cameron's Law H.R.1532 - Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1492 - Ensuring Pathways to Innovative Cures (EPIC) Act
H.R.1262/S.932 - Give Kids a Chance Act H.R.946 - ORPHAN Cures Act H.R. 1414 - Cameron's Law H.R.1532/S.822 - Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1492 - Ensuring Pathways to Innovative Cures (EPIC) Act
H.R.1262/S.932 - Give Kids a Chance Act H.R.946 - ORPHAN Cures Act H.R. 1414 - Cameron's Law H.R.1532/S.822 - Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1492 - Ensuring Pathways to Innovative Cures (EPIC) Act
H.R.1262/S.932 - Give Kids a Chance Act H.R.946 - ORPHAN Cures Act H.R. 1414 - Cameron's Law H.R.1532/S.822 - Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1492 - Ensuring Pathways to Innovative Cures (EPIC) Act
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
Keep Innovation in America Act
Client: ASTRIA THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
Keep Innovation in America Act
Client: ASTRIA THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
Keep Innovation in America Act
Client: ASTRIA THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
Keep Innovation in America Act
Client: ASTRIA THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
Healthy Food Financing Initiative Reauthorization Act of 2023
Client: ASTRIA THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
Healthy Food Financing Initiative Reauthorization Act of 2023
Client: ASTRIA THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
Healthy Food Financing Initiative Reauthorization Act of 2023
Client: ASTRIA THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
Healthy Food Financing Initiative Reauthorization Act of 2023
Client: ASTRIA THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
To authorize any Indian Tribe to lease, sell, convey, warrant, or otherwise transfer real property to which that Indian Tribe holds fee title without the consent of the Federal Government, and for other purposes.
Client: ASTRIA THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
To authorize any Indian Tribe to lease, sell, convey, warrant, or otherwise transfer real property to which that Indian Tribe holds fee title without the consent of the Federal Government, and for other purposes.
Client: ASTRIA THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
To authorize any Indian Tribe to lease, sell, convey, warrant, or otherwise transfer real property to which that Indian Tribe holds fee title without the consent of the Federal Government, and for other purposes.
Client: ASTRIA THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
To authorize any Indian Tribe to lease, sell, convey, warrant, or otherwise transfer real property to which that Indian Tribe holds fee title without the consent of the Federal Government, and for other purposes.
Client: ASTRIA THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Institute on Drug Abuse for fiscal year 2024.
Client: ASTRIA THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Institute on Drug Abuse for fiscal year 2024.
Client: ASTRIA THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Institute on Drug Abuse for fiscal year 2024.
Client: ASTRIA THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Institute on Drug Abuse for fiscal year 2024.
Client: ASTRIA THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
Improving Seniors’ Timely Access to Care Act of 2024
Client: ASTRIA THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
Improving Seniors’ Timely Access to Care Act of 2024
Client: ASTRIA THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
Improving Seniors’ Timely Access to Care Act of 2024
Client: ASTRIA THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
Improving Seniors’ Timely Access to Care Act of 2024
Client: ASTRIA THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
S.4426, Promising Pathway Act 2.0 (118th Congress)
S.4426, Promising Pathway Act 2.0 (118th Congress)
S.4426, Promising Pathway Act 2.0 (118th Congress)
Improving Seniors’ Timely Access to Care Act of 2024
Client: ASTRIA THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
Improving Seniors’ Timely Access to Care Act of 2024
Client: ASTRIA THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
Improving Seniors’ Timely Access to Care Act of 2024
Client: ASTRIA THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
Improving Seniors’ Timely Access to Care Act of 2024
Client: ASTRIA THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
Preventing Violence Against Female Inmates Act of 2023
Client: ASTRIA THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
Preventing Violence Against Female Inmates Act of 2023
Client: ASTRIA THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
Preventing Violence Against Female Inmates Act of 2023
Client: ASTRIA THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
Preventing Violence Against Female Inmates Act of 2023
Client: ASTRIA THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
Modification to Department of Defense Travel Authorities for Abortion-Related Expenses Act of 2023
Client: ASTRIA THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
Modification to Department of Defense Travel Authorities for Abortion-Related Expenses Act of 2023
Client: ASTRIA THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
Modification to Department of Defense Travel Authorities for Abortion-Related Expenses Act of 2023
Client: ASTRIA THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
Modification to Department of Defense Travel Authorities for Abortion-Related Expenses Act of 2023
Client: ASTRIA THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
H.R.6664 - Innovation in Pediatric Drugs Act of 2023 H.R.7384 - Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act H.R. 7384, Creating Hope Reauthorization Act of 2024 S. 652, Safe Step Act H.R.1092, Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2023 S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 830/S. 1375, HELP Copays Act H.R. 883/S. 320, Stop the Wait Act of 2023 H.R. 4758/S.2372, Accelerating Kids Access to Care Act H.R. 6094, Providing Realistic Opportunity To Equal and Comparable Treatment for (PROTECT) Rare Act
Healthy Dog Importation Act
Client: RARE DISEASE COMPANY COALITION · Firm: THE KPM GROUP DC LLC
H.R. 7384, Creating Hope Reauthorization Act S.2372/H.R.4758, Accelerating Kids Access to Care Act H.R.6664, Innovation in Pediatric Drugs Act of 2023 H.R.5539/S.3131, the ORPHAN Cures Act H.R.1184/S.4071, the Helping Experts Accelerate Rare Treatments Act
H.R. 830/S. 1375, HELP Copays Act H.R. 2630/S. 652, Safe Step Act H.R. 2673, American Innovation and R&D Competitiveness Act of 2023 H.R.5539/S.3131, ORPHAN Cures Act H.R.7384, the Creating Hope Reauthorization Act of 2024 H.R.4408/S.1906, Promising Pathway Act
American Innovation and R&D Competitiveness Act of 2023
Client: ASTRIA THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R. 830/S. 1375, HELP Copays Act H.R. 2630/S. 652, Safe Step Act H.R. 2673, American Innovation and R&D Competitiveness Act of 2023 H.R.5539/S.3131, ORPHAN Cures Act H.R.7384, the Creating Hope Reauthorization Act of 2024 H.R.4408/S.1906, Promising Pathway Act
H.R. 830/S. 1375, HELP Copays Act H.R. 2630/S. 652, Safe Step Act H.R. 2673, American Innovation and R&D Competitiveness Act of 2023 H.R.5539/S.3131, ORPHAN Cures Act H.R.7384, the Creating Hope Reauthorization Act of 2024 H.R.4408/S.1906, Promising Pathway Act
Accelerating Kids’ Access to Care Act
Client: FULCRUM THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R.6664 - Innovation in Pediatric Drugs Act of 2023 H.R.7384 - Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act H.R. 7384, Creating Hope Reauthorization Act of 2024 S. 652, Safe Step Act H.R.1092, Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2023 S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 830/S. 1375, HELP Copays Act H.R. 883/S. 320, Stop the Wait Act of 2023 H.R. 4758/S.2372, Accelerating Kids Access to Care Act H.R. 6094, Providing Realistic Opportunity To Equal and Comparable Treatment for (PROTECT) Rare Act
Accelerating Kids’ Access to Care Act
Client: RARE DISEASE COMPANY COALITION · Firm: THE KPM GROUP DC LLC
H.R. 7384, Creating Hope Reauthorization Act S.2372/H.R.4758, Accelerating Kids Access to Care Act H.R.6664, Innovation in Pediatric Drugs Act of 2023 H.R.5539/S.3131, the ORPHAN Cures Act H.R.1184/S.4071, the Helping Experts Accelerate Rare Treatments Act
Accelerating Kids’ Access to Care Act
Client: RARE DISEASE COMPANY COALITION · Firm: THE KPM GROUP DC LLC
S. 1906, the Promising Pathway Act H.R.5539/S.3131, the ORPHAN Cures Act H.R. 7384, the Creating Hope Reauthorization Act H.R.4758/S.2372, the Accelerating Kids Access to Care Act H.R.6664, the Innovation in Pediatric Drugs Act H.R.1184/S.4071, the Helping Experts Accelerate Rare Treatments Act
H.R. 830/S. 1375, HELP Copays Act H.R. 2630/S. 652, Safe Step Act H.R. 2673, American Innovation and R&D Competitiveness Act of 2023 H.R.5539/S.3131, ORPHAN Cures Act H.R.7384, the Creating Hope Reauthorization Act of 2024 H.R.4408/S.1906, Promising Pathway Act
H.R. 7384, Creating Hope Reauthorization Act S.2372/H.R.4758, Accelerating Kids Access to Care Act H.R.6664, Innovation in Pediatric Drugs Act of 2023 H.R.5539/S.3131, the ORPHAN Cures Act H.R.1184/S.4071, the Helping Experts Accelerate Rare Treatments Act
S. 1906, the Promising Pathway Act H.R.5539/S.3131, the ORPHAN Cures Act H.R. 7384, the Creating Hope Reauthorization Act H.R.4758/S.2372, the Accelerating Kids Access to Care Act H.R.6664, the Innovation in Pediatric Drugs Act H.R.1184/S.4071, the Helping Experts Accelerate Rare Treatments Act
Providing Realistic Opportunity To Equal and Comparable Treatment for Rare Act
Client: FULCRUM THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R.6664 - Innovation in Pediatric Drugs Act of 2023 H.R.7384 - Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act H.R. 7384, Creating Hope Reauthorization Act of 2024 S. 652, Safe Step Act H.R.1092, Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2023 S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 830/S. 1375, HELP Copays Act H.R. 883/S. 320, Stop the Wait Act of 2023 H.R. 4758/S.2372, Accelerating Kids Access to Care Act H.R. 6094, Providing Realistic Opportunity To Equal and Comparable Treatment for (PROTECT) Rare Act
Innovation in Pediatric Drugs Act of 2023
Client: RARE DISEASE COMPANY COALITION · Firm: THE KPM GROUP DC LLC
S. 1906, the Promising Pathway Act H.R.5539/S.3131, the ORPHAN Cures Act H.R. 7384, the Creating Hope Reauthorization Act H.R.4758/S.2372, the Accelerating Kids Access to Care Act H.R.6664, the Innovation in Pediatric Drugs Act H.R.1184/S.4071, the Helping Experts Accelerate Rare Treatments Act
Innovation in Pediatric Drugs Act of 2023
Client: FULCRUM THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R.6664 - Innovation in Pediatric Drugs Act of 2023 H.R.7384 - Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act H.R. 7384, Creating Hope Reauthorization Act of 2024 S. 652, Safe Step Act H.R.1092, Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2023 S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 830/S. 1375, HELP Copays Act H.R. 883/S. 320, Stop the Wait Act of 2023 H.R. 4758/S.2372, Accelerating Kids Access to Care Act H.R. 6094, Providing Realistic Opportunity To Equal and Comparable Treatment for (PROTECT) Rare Act
Innovation in Pediatric Drugs Act of 2023
Client: RARE DISEASE COMPANY COALITION · Firm: THE KPM GROUP DC LLC
H.R. 7384, Creating Hope Reauthorization Act S.2372/H.R.4758, Accelerating Kids Access to Care Act H.R.6664, Innovation in Pediatric Drugs Act of 2023 H.R.5539/S.3131, the ORPHAN Cures Act H.R.1184/S.4071, the Helping Experts Accelerate Rare Treatments Act
Creating Hope Reauthorization Act of 2024
Client: RARE DISEASE COMPANY COALITION · Firm: THE KPM GROUP DC LLC
S. 1906, the Promising Pathway Act H.R.5539/S.3131, the ORPHAN Cures Act H.R. 7384, the Creating Hope Reauthorization Act H.R.4758/S.2372, the Accelerating Kids Access to Care Act H.R.6664, the Innovation in Pediatric Drugs Act H.R.1184/S.4071, the Helping Experts Accelerate Rare Treatments Act
Creating Hope Reauthorization Act of 2024
Client: RARE DISEASE COMPANY COALITION · Firm: THE KPM GROUP DC LLC
H.R. 7384, Creating Hope Reauthorization Act S.2372/H.R.4758, Accelerating Kids Access to Care Act H.R.6664, Innovation in Pediatric Drugs Act of 2023 H.R.5539/S.3131, the ORPHAN Cures Act H.R.1184/S.4071, the Helping Experts Accelerate Rare Treatments Act
Creating Hope Reauthorization Act of 2024
Client: ASTRIA THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R. 830/S. 1375, HELP Copays Act H.R. 2630/S. 652, Safe Step Act H.R. 2673, American Innovation and R&D Competitiveness Act of 2023 H.R.5539/S.3131, ORPHAN Cures Act H.R.7384, the Creating Hope Reauthorization Act of 2024 H.R.4408/S.1906, Promising Pathway Act
Creating Hope Reauthorization Act of 2024
Client: FULCRUM THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R.6664 - Innovation in Pediatric Drugs Act of 2023 H.R.7384 - Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act H.R. 7384, Creating Hope Reauthorization Act of 2024 S. 652, Safe Step Act H.R.1092, Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2023 S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 830/S. 1375, HELP Copays Act H.R. 883/S. 320, Stop the Wait Act of 2023 H.R. 4758/S.2372, Accelerating Kids Access to Care Act H.R. 6094, Providing Realistic Opportunity To Equal and Comparable Treatment for (PROTECT) Rare Act
Sickle Cell Disease Comprehensive Care Act
Client: FULCRUM THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R.6664 - Innovation in Pediatric Drugs Act of 2023 H.R.7384 - Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act H.R. 7384, Creating Hope Reauthorization Act of 2024 S. 652, Safe Step Act H.R.1092, Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2023 S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 830/S. 1375, HELP Copays Act H.R. 883/S. 320, Stop the Wait Act of 2023 H.R. 4758/S.2372, Accelerating Kids Access to Care Act H.R. 6094, Providing Realistic Opportunity To Equal and Comparable Treatment for (PROTECT) Rare Act
H.R.6664 - Innovation in Pediatric Drugs Act of 2023 H.R.7384 - Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act H.R. 7384, Creating Hope Reauthorization Act of 2024 S. 652, Safe Step Act H.R.1092, Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2023 S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 830/S. 1375, HELP Copays Act H.R. 883/S. 320, Stop the Wait Act of 2023 H.R. 4758/S.2372, Accelerating Kids Access to Care Act H.R. 6094, Providing Realistic Opportunity To Equal and Comparable Treatment for (PROTECT) Rare Act
H.R. 830/S. 1375, HELP Copays Act H.R. 2630/S. 652, Safe Step Act H.R. 2673, American Innovation and R&D Competitiveness Act of 2023 H.R.5539/S.3131, ORPHAN Cures Act H.R.7384, the Creating Hope Reauthorization Act of 2024 H.R.4408/S.1906, Promising Pathway Act
H.R.6664 - Innovation in Pediatric Drugs Act of 2023 H.R.7384 - Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act H.R. 7384, Creating Hope Reauthorization Act of 2024 S. 652, Safe Step Act H.R.1092, Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2023 S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 830/S. 1375, HELP Copays Act H.R. 883/S. 320, Stop the Wait Act of 2023 H.R. 4758/S.2372, Accelerating Kids Access to Care Act H.R. 6094, Providing Realistic Opportunity To Equal and Comparable Treatment for (PROTECT) Rare Act
Expressing support for the designation of June 20, 2024, as "World FSHD Day".
Client: FULCRUM THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R.6664 - Innovation in Pediatric Drugs Act of 2023 H.R.7384 - Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act H.R. 7384, Creating Hope Reauthorization Act of 2024 S. 652, Safe Step Act H.R.1092, Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2023 S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 830/S. 1375, HELP Copays Act H.R. 883/S. 320, Stop the Wait Act of 2023 H.R. 4758/S.2372, Accelerating Kids Access to Care Act H.R. 6094, Providing Realistic Opportunity To Equal and Comparable Treatment for (PROTECT) Rare Act
H.R. 830/S. 1375, HELP Copays Act H.R. 2630/S. 652, Safe Step Act H.R. 2673, American Innovation and R&D Competitiveness Act of 2023 H.R.5539/S.3131, ORPHAN Cures Act H.R.7384, the Creating Hope Reauthorization Act of 2024 H.R.4408/S.1906, Promising Pathway Act
H.R.6664 - Innovation in Pediatric Drugs Act of 2023 H.R.7384 - Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act H.R. 7384, Creating Hope Reauthorization Act of 2024 S. 652, Safe Step Act H.R.1092, Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2023 S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 830/S. 1375, HELP Copays Act H.R. 883/S. 320, Stop the Wait Act of 2023 H.R. 4758/S.2372, Accelerating Kids Access to Care Act H.R. 6094, Providing Realistic Opportunity To Equal and Comparable Treatment for (PROTECT) Rare Act
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023
Client: FULCRUM THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R.6664 - Innovation in Pediatric Drugs Act of 2023 H.R.7384 - Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act H.R. 7384, Creating Hope Reauthorization Act of 2024 S. 652, Safe Step Act H.R.1092, Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2023 S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 830/S. 1375, HELP Copays Act H.R. 883/S. 320, Stop the Wait Act of 2023 H.R. 4758/S.2372, Accelerating Kids Access to Care Act H.R. 6094, Providing Realistic Opportunity To Equal and Comparable Treatment for (PROTECT) Rare Act
H.R. 830/S. 1375, HELP Copays Act H.R. 2630/S. 652, Safe Step Act H.R. 2673, American Innovation and R&D Competitiveness Act of 2023 H.R.5539/S.3131, ORPHAN Cures Act H.R.7384, the Creating Hope Reauthorization Act of 2024 H.R.4408/S.1906, Promising Pathway Act
S. 1906, the Promising Pathway Act H.R.5539/S.3131, the ORPHAN Cures Act H.R. 7384, the Creating Hope Reauthorization Act H.R.4758/S.2372, the Accelerating Kids Access to Care Act H.R.6664, the Innovation in Pediatric Drugs Act H.R.1184/S.4071, the Helping Experts Accelerate Rare Treatments Act
Accelerating Kids’ Access to Care Act
Client: RARE DISEASE COMPANY COALITION · Firm: THE KPM GROUP DC LLC
H.R. 7384, Creating Hope Reauthorization Act S.2372/H.R.4758, Accelerating Kids Access to Care Act H.R.6664, Innovation in Pediatric Drugs Act of 2023 H.R.5539/S.3131, the ORPHAN Cures Act H.R.1184/S.4071, the Helping Experts Accelerate Rare Treatments Act
Accelerating Kids’ Access to Care Act
Client: FULCRUM THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R.6664 - Innovation in Pediatric Drugs Act of 2023 H.R.7384 - Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act H.R. 7384, Creating Hope Reauthorization Act of 2024 S. 652, Safe Step Act H.R.1092, Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2023 S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 830/S. 1375, HELP Copays Act H.R. 883/S. 320, Stop the Wait Act of 2023 H.R. 4758/S.2372, Accelerating Kids Access to Care Act H.R. 6094, Providing Realistic Opportunity To Equal and Comparable Treatment for (PROTECT) Rare Act
Accelerating Kids’ Access to Care Act
Client: RARE DISEASE COMPANY COALITION · Firm: THE KPM GROUP DC LLC
S. 1906, the Promising Pathway Act H.R.5539/S.3131, the ORPHAN Cures Act H.R. 7384, the Creating Hope Reauthorization Act H.R.4758/S.2372, the Accelerating Kids Access to Care Act H.R.6664, the Innovation in Pediatric Drugs Act H.R.1184/S.4071, the Helping Experts Accelerate Rare Treatments Act
H.R. 7384, Creating Hope Reauthorization Act S.2372/H.R.4758, Accelerating Kids Access to Care Act H.R.6664, Innovation in Pediatric Drugs Act of 2023 H.R.5539/S.3131, the ORPHAN Cures Act H.R.1184/S.4071, the Helping Experts Accelerate Rare Treatments Act
S. 1906, the Promising Pathway Act H.R.5539/S.3131, the ORPHAN Cures Act H.R. 7384, the Creating Hope Reauthorization Act H.R.4758/S.2372, the Accelerating Kids Access to Care Act H.R.6664, the Innovation in Pediatric Drugs Act H.R.1184/S.4071, the Helping Experts Accelerate Rare Treatments Act
H.R. 830/S. 1375, HELP Copays Act H.R. 2630/S. 652, Safe Step Act H.R. 2673, American Innovation and R&D Competitiveness Act of 2023 H.R.5539/S.3131, ORPHAN Cures Act H.R.7384, the Creating Hope Reauthorization Act of 2024 H.R.4408/S.1906, Promising Pathway Act
H.R.6664 - Innovation in Pediatric Drugs Act of 2023 H.R.7384 - Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act H.R. 7384, Creating Hope Reauthorization Act of 2024 S. 652, Safe Step Act H.R.1092, Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2023 S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 830/S. 1375, HELP Copays Act H.R. 883/S. 320, Stop the Wait Act of 2023 H.R. 4758/S.2372, Accelerating Kids Access to Care Act H.R. 6094, Providing Realistic Opportunity To Equal and Comparable Treatment for (PROTECT) Rare Act
Office of Colonias and Farmworker Initiatives Establishment Act of 2024
Client: RARE DISEASE COMPANY COALITION · Firm: THE KPM GROUP DC LLC
H.R. 7384, Creating Hope Reauthorization Act S.2372/H.R.4758, Accelerating Kids Access to Care Act H.R.6664, Innovation in Pediatric Drugs Act of 2023 H.R.5539/S.3131, the ORPHAN Cures Act H.R.1184/S.4071, the Helping Experts Accelerate Rare Treatments Act
H.R. 830/S. 1375, HELP Copays Act H.R. 2630/S. 652, Safe Step Act H.R. 2673, American Innovation and R&D Competitiveness Act of 2023 H.R.5539/S.3131, ORPHAN Cures Act H.R.7384, the Creating Hope Reauthorization Act of 2024 H.R.4408/S.1906, Promising Pathway Act
H.R.6664 - Innovation in Pediatric Drugs Act of 2023 H.R.7384 - Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act H.R. 7384, Creating Hope Reauthorization Act of 2024 S. 652, Safe Step Act H.R.1092, Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2023 S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 830/S. 1375, HELP Copays Act H.R. 883/S. 320, Stop the Wait Act of 2023 H.R. 4758/S.2372, Accelerating Kids Access to Care Act H.R. 6094, Providing Realistic Opportunity To Equal and Comparable Treatment for (PROTECT) Rare Act
Helping Experts Accelerate Rare Treatments Act of 2021
Client: RARE DISEASE COMPANY COALITION · Firm: THE KPM GROUP DC LLC
S. 1906, the Promising Pathway Act H.R.5539/S.3131, the ORPHAN Cures Act H.R. 7384, the Creating Hope Reauthorization Act H.R.4758/S.2372, the Accelerating Kids Access to Care Act H.R.6664, the Innovation in Pediatric Drugs Act H.R.1184/S.4071, the Helping Experts Accelerate Rare Treatments Act
FDA appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRAXIS PRECISION MEDICINES via THE KPM GROUP DC LLC
2026 · second_quarter · 2A
FDA appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AZURITY PHARMACEUTICALS, INC. via THE KPM GROUP DC LLC
2026 · second_quarter · Q2
Colorectal cancer bowel prep
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AZURITY PHARMACEUTICALS, INC. via THE KPM GROUP DC LLC
2026 · second_quarter · RR
Colorectal cancer bowel prep
MAHZI THERAPEUTICS via THE KPM GROUP DC LLC
2026 · first_quarter · Q1
Priority review voucher (PRV) re-authorization, ICD-10 codes
Priority review voucher (PRV) re-authorization, ICD-10 codes
Priority review voucher (PRV) re-authorization, ICD-10 codes
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REZOLUTE via THE KPM GROUP DC LLC
2026 · first_quarter · Q1
S.4426, Promising Pathway Act 2.0 (118th Congress)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MAHZI THERAPEUTICS via THE KPM GROUP DC LLC
2026 · first_quarter · RR
Priority review voucher (PRV) re-authorization, ICD-10 codes
Priority review voucher (PRV) re-authorization, ICD-10 codes
Priority review voucher (PRV) re-authorization, ICD-10 codes
ASTRIA THERAPEUTICS, INC. via THE KPM GROUP DC LLC
2025 · fourth_quarter · 4T
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REZOLUTE via THE KPM GROUP DC LLC
2025 · fourth_quarter · Q4
S.4426, Promising Pathway Act 2.0 (118th Congress)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REZOLUTE via THE KPM GROUP DC LLC
2025 · third_quarter · Q3
S.4426, Promising Pathway Act 2.0 (118th Congress)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASTRIA THERAPEUTICS, INC. via THE KPM GROUP DC LLC
2025 · third_quarter · Q3
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASTRIA THERAPEUTICS, INC. via THE KPM GROUP DC LLC
2025 · second_quarter · Q2
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INOZYME PHARMA via THE KPM GROUP DC LLC
2025 · second_quarter · Q2
H.R.1262/S.932 - Give Kids a Chance Act H.R.946 - ORPHAN Cures Act H.R. 1414 - Cameron's Law H.R.1532/S.822 - Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1492 - Ensuring Pathways to Innovative Cures (EPIC) Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REZOLUTE via THE KPM GROUP DC LLC
2025 · second_quarter · Q2
S.4426, Promising Pathway Act 2.0 (118th Congress)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REZOLUTE via THE KPM GROUP DC LLC
2025 · second_quarter · RA
FDA Issues and health care reform
INOZYME PHARMA via THE KPM GROUP DC LLC
2025 · second_quarter · RR
FDA modernization H.R.1262 - Give Kids a Chance Act Trump administration impact on staffing at HHS and FDA Newborn screening Inflation Reduction Act (IRA) H.R.946 - ORPHAN Cures Act H.R. 1414 - Cameron's Law H.R.1532 - Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1492 - Ensuring Pathways to Innovative Cures (EPIC) Act
ASTRIA THERAPEUTICS, INC. via THE KPM GROUP DC LLC
2025 · first_quarter · Q1
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE DISEASE COMPANY COALITION via THE KPM GROUP DC LLC
2024 · second_quarter · Q2
H.R. 7384, Creating Hope Reauthorization Act S.2372/H.R.4758, Accelerating Kids Access to Care Act H.R.6664, Innovation in Pediatric Drugs Act of 2023 H.R.5539/S.3131, the ORPHAN Cures Act H.R.1184/S.4071, the Helping Experts Accelerate Rare Treatments Act
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
FULCRUM THERAPEUTICS, INC. via THE KPM GROUP DC LLC
2024 · second_quarter · Q2
H.R.6664 - Innovation in Pediatric Drugs Act of 2023 H.R.7384 - Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act H.R. 7384, Creating Hope Reauthorization Act of 2024 S. 652, Safe Step Act H.R.1092, Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2023 S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 830/S. 1375, HELP Copays Act H.R. 883/S. 320, Stop the Wait Act of 2023 H.R. 4758/S.2372, Accelerating Kids Access to Care Act H.R. 6094, Providing Realistic Opportunity To Equal and Comparable Treatment for (PROTECT) Rare Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASTRIA THERAPEUTICS, INC. via THE KPM GROUP DC LLC
2024 · second_quarter · Q2
H.R. 830/S. 1375, HELP Copays Act H.R. 2630/S. 652, Safe Step Act H.R. 2673, American Innovation and R&D Competitiveness Act of 2023 H.R.5539/S.3131, ORPHAN Cures Act H.R.7384, the Creating Hope Reauthorization Act of 2024 H.R.4408/S.1906, Promising Pathway Act
Filing targets: HOUSE OF REPRESENTATIVES
RARE DISEASE COMPANY COALITION via THE KPM GROUP DC LLC
2024 · first_quarter · Q1
S. 1906, the Promising Pathway Act H.R.5539/S.3131, the ORPHAN Cures Act H.R. 7384, the Creating Hope Reauthorization Act H.R.4758/S.2372, the Accelerating Kids Access to Care Act H.R.6664, the Innovation in Pediatric Drugs Act H.R.1184/S.4071, the Helping Experts Accelerate Rare Treatments Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE DISEASE COMPANY COALITION via THE KPM GROUP DC LLC
2023 · fourth_quarter · Q4
H.R. 5339/S. 3131, Orphan Cures Act S. 866, American Innovation and Jobs Act FDA Reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASTRIA THERAPEUTICS, INC. via THE KPM GROUP DC LLC
2023 · fourth_quarter · Q4
H.R. 830/S. 1375, HELP Copays Act H.R. 2673, American Innovation and R&D Competitiveness Act of 2023 H.R. 2630/S. 652, Safe Step Act S. 866, American Innovation and Jobs Act S. 1906 Promising Pathway Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE DISEASE COMPANY COALITION via THE KPM GROUP DC LLC
2023 · third_quarter · Q3
H.R. 1350 - Camerons Law H.R. 1805 - Leos Law H.R. 5376 - Inflation Reduction Act of 2022 (117th) H.R. 5539 - ORPHAN Cures Act S. 1214 - RARE Act
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
ASTRIA THERAPEUTICS, INC. via THE KPM GROUP DC LLC
2023 · third_quarter · RR
FDA issues and health care reform
JEREMY LEVIN via THE KPM GROUP DC LLC
2023 · second_quarter · Q2
Israel Judicial reforms proposed by PM Netanyahu
Filing targets: SENATE
RARE DISEASE COMPANY COALITION via THE KPM GROUP DC LLC
2023 · second_quarter · Q2
H.R. 485 - Protecting Health Care for All Patients Act of 2023 H.R.1350 - Camerons Law H.R.1805 - Leos Law S.866 - American Innovation and Jobs Act H.R.2673 - American Innovation and R&D Competitiveness Act of 2023 H.R.5376 - Inflation Reduction Act of 2022 (117th) H.R.2471 - Consolidated Appropriations Act, 2022 (117th)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE DISEASE COMPANY COALITION via THE KPM GROUP DC LLC
2023 · first_quarter · Q1
H.R.5376 - Inflation Reduction Act of 2022 (117th) H.R.2471 - Consolidated Appropriations Act, 2022 (117th) H.R.485 - Protecting Health Care for All Patients Act of 2023 H.R.1350 - Camerons Law H.R.8641 - Orphan Drug COVID-19 Mitigation Act of 2022 (117th) S.46 - American Innovation and Manufacturing Act
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
JEREMY LEVIN via THE KPM GROUP DC LLC
2023 · first_quarter · Q1
Israel Judicial reforms proposed by PM Netanyahu
Filing targets: SENATE
GENSIGHT BIOLOGICS S.A. via THE KPM GROUP DC LLC
2023 · first_quarter · RR
Rare disease drug development Orphan Drug Act Orphan Drug Tax Credit Priority Review Voucher Expedited approval pathways Patient-focused drug development
Rare disease drug development Orphan Drug Act Orphan Drug Tax Credit Priority Review Voucher Expedited approval pathways Patient-focused drug development
JEREMY LEVIN via THE KPM GROUP DC LLC
2023 · first_quarter · RR
Issues related to Israel Security
RARE DISEASE COMPANY COALITION via THE KPM GROUP DC LLC
2022 · fourth_quarter · Q4
H.R. 2617, the Consolidated Appropriations Act, 2023 S. 4348, the FDASLA Act of 2022 H.R. 7667, the Food and Drug Amendments of 2022 H.R. 5376, the Inflation Reduction Act of 2022 Public Law 97-414, the Orphan Drug Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE DISEASE COMPANY COALITION via THE KPM GROUP DC LLC
2022 · third_quarter · Q3
S. 4348, the FDASLA Act of 2022 H.R. 7667, the Food and Drug Amendments of 2022 H.R. 5376, the Inflation Reduction Act of 2022 Public Law 97-414, the Orphan Drug Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE DISEASE COMPANY COALITION via THE KPM GROUP DC LLC
2022 · second_quarter · Q2
S. 373 H.R. 4472 H.R. 7667 S. 4348 S. 4071, the Helping Experts Accelerate Rare Treatments (HEART) Act S. 373/H.R. 4472, the Better Empowerment Now to Enhance Framework and Improve Treatments (BENEFIT) Act Orphan Drug Tax Credit
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE DISEASE COMPANY COALITION via THE KPM GROUP DC LLC
2022 · first_quarter · Q1
H.R. 5989 Precision Medicine Answers for Kids Today Act H.R. 6963 Accelerated Approval Integrity Act of 2022 H.R. 6996 Accelerating Access for Patients Act of 2022 H.R. 5585 Advanced Research Project Agency-Health Act H.R. 4472 BENEFIT Act of 2021
H.R. 5376, the Build Back Better Act H.R. 6000, Cures 2.0 Act H.R. 2623, Camerons Law
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ULTRAGENYX PHARMACEUTICAL via THE KPM GROUP DC LLC
2021 · fourth_quarter · Q4
H.R. 5376, the Build Back Better Act
Orphan Drug Tax Credit
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COGNOA, INC. via THE KPM GROUP DC LLC
2021 · fourth_quarter · RR
Market Access and Reimbursement Pediatric Behavioral Health Autism Spectrum Disorder (ASD) Digital Therapeutics/Digital Health AI/ML/IP in Healthcare Clinical Practice Guidelines (CPG) Tricare Comprehensive Autism Care Demonstration (military health)
RELMADA THERAPEUTICS, INC. via THE KPM GROUP DC LLC
2021 · fourth_quarter · RR
mental and behavioral health policy proposals and CMS coverage
ZAMBON USA via THE KPM GROUP DC LLC
2021 · third_quarter · Q3
Cures 2.0 (not introduced yet)
Burn Pits Legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE DISEASE COMPANY COALITION via THE KPM GROUP DC LLC
2021 · third_quarter · Q3
Senate Finance Committee Drug Pricing Principles Orphan Drug Tax Credit
H.R. 482/ S. 350, the Newborn Screening Saves Lives Reauthorization Act Build Back Better Act Cures 2.0
Medicare Negotiation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE BRAIN DONOR PROJECT via THE KPM GROUP DC LLC
2021 · third_quarter · Q3
NIH/NeuroBioBank Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MANNKIND CORPORATION via THE KPM GROUP DC LLC
2021 · third_quarter · Q3
CMS Medicare Part D Senior Savings Model
Filing targets: HOUSE OF REPRESENTATIVES
CHIESI USA, INC. via THE KPM GROUP DC LLC
2021 · third_quarter · Q3
FDA Inspections
H.R. 1730/S. 670, the Speeding Therapy Access Today (STAT) Act H.R. 2623, Camerons Law MACPAC Accelerated Approval Pathway Recommendations Cures 2.0 (not introduced yet)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AEGLEA BIOTHERAPEUTICS, INC. via THE KPM GROUP DC LLC
2021 · third_quarter · Q3
S. 670/H.R. 1730, the Speeding Therapy Access Today (STAT) Act H.R. 482/ S. 350, the Newborn Screening Saves Lives Reauthorization Act H.R. 3783/S. 2013, the Medical Nutrition Equity Act of 2021 Cures 2.0 (not introduced yet)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ULTRAGENYX PHARMACEUTICAL via THE KPM GROUP DC LLC
2021 · third_quarter · Q3
H.R. 482/ S. 350, the Newborn Screening Saves Lives Speeding Therapy Access Today (STAT) Act - H.R. 1730/S. 670 Ensuring Lasting Smiles Act H.R. 1916/S. 754 HEART Act of 2020 - H.R. 7567 Reauthorization Act Cures 2.0
Fairness in Orphan Drug Exclusivity Act S. 250 Senate Finance Committee Drug Pricing Principles
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE DISEASE COMPANY COALITION via THE KPM GROUP DC LLC
2021 · second_quarter · Q2
H.R. 482/ S.350, the Newborn Screening Saves Lives Reauthorization Act MACPAC Accelerated Approval Pathway Recommendations
Senate Finance Committee Drug Pricing Principles
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL BOARD FOR CERTIFIED COUNSELORS AND AFFILIATES, INC. via THE KPM GROUP DC LLC
2021 · fourth_quarter · RR
Adding mental health counselors as an eligible provider of psychotherapy services under Medicare Part B Increase hiring of mental health counselors by the Department of Veteran's Affairs Increasing funding for SAMHSA's Minority Fellowship Program Ensuring the inclusion of counselors in telehealth measures
Adding mental health counselors as an eligible provider of psychotherapy services under Medicare Part B Increase hiring of mental health counselors by the Department of Veteran's Affairs Increasing funding for SAMHSA's Minority Fellowship Program Ensuring the inclusion of counselors in telehealth measures
RARE DISEASE COMPANY COALITION via THE KPM GROUP DC LLC
2021 · first_quarter · RR
Treatment of rare diseases.
ATAI LIFE SCIENCES N.V. via THE KPM GROUP DC LLC
2021 · second_quarter · 2A
Coverage and Reimbursement for Mental Health Services
DEA Restrictions on Psychedelics
Filing targets: HOUSE OF REPRESENTATIVES
ATAI LIFE SCIENCES N.V. via THE KPM GROUP DC LLC
2021 · second_quarter · RR
DEA Restrictions on Psychedelics; Coverage and Reimbursement for Mental Health Services
DEA Restrictions on Psychedelics; Coverage and Reimbursement for Mental Health Services
THE BRAIN DONOR PROJECT via THE KPM GROUP DC LLC
2021 · second_quarter · RR
Discuss mission to raise awareness for brain donation; increased funding for NIH
PHARMAESSENTIA CORPORATION via THE KPM GROUP DC LLC
2021 · second_quarter · 2A
FDA Foreign Inspections Backlog
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MANNKIND CORPORATION via THE KPM GROUP DC LLC
2021 · second_quarter · 2A
CMS Medicare Part D Senior Savings Model
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZAMBON USA via THE KPM GROUP DC LLC
2021 · second_quarter · Q2
Introductory Meeting; Burn Pits Legislation
Filing targets: HOUSE OF REPRESENTATIVES
ULTRAGENYX PHARMACEUTICAL via THE KPM GROUP DC LLC
2021 · second_quarter · Q2
H.R. 1730/S. 670, STAT Act H.R. 482/S. 350, Newborn Screening Reauthorization Act H.R. 1916/S.754, Ensuring Lasting Smiles Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AEGLEA BIOTHERAPEUTICS, INC. via THE KPM GROUP DC LLC
2021 · second_quarter · Q2
H.R. 1730/S. 670, STAT Act H.R. 482/S. 350, Newborn Screening Reauthorization Act Cures 2.0 (not introduced)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOAGILYTIX LABS, LLC via THE KPM GROUP DC LLC
2021 · first_quarter · RR
Cures 2.0, sitting on advisory committees/panels, FDA reform
MANNKIND CORPORATION via THE KPM GROUP DC LLC
2021 · first_quarter · Q1
PPE Production through DPA
CMS Medicare Part D Senior Savings Model
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ORPHAZYME US, INC. via THE KPM GROUP DC LLC
2021 · first_quarter · Q1
H.R. 1730/S. 670, Speeding Therapy Access Today (STAT) Act H.R. 482/S. 350, Newborn Screening Reauthorization Act
Filing targets: SENATE
SANGAMO THERAPEUTICS, INC via THE KPM GROUP DC LLC
2021 · first_quarter · Q1
Advancing Access to Precision Medicine Act (not introduced) H.R. 1730/S. 670, Speeding Therapy Access Today (STAT) Act Cures 2.0 (not introduced) PDUFA VII Reauthorization
Filing targets: HOUSE OF REPRESENTATIVES
ACCELERON PHARMA via THE KPM GROUP DC LLC
2021 · first_quarter · RR
drug pricing, rare disease issues, Medicare Part D
drug pricing, rare disease issues, Medicare Part D
PHARMAESSENTIA CORPORATION via THE KPM GROUP DC LLC
2021 · second_quarter · RR
FDA inspections
GRITSTONE ONCOLOGY via THE KPM GROUP DC LLC
2021 · first_quarter · Q1
COVID-19 vaccine development - manufacturing scale-up assistance
Filing targets: SENATE
AEGLEA BIOTHERAPEUTICS, INC. via THE KPM GROUP DC LLC
2021 · first_quarter · Q1
H.R. 1730/S. 670, STAT Act H.R. 482/S. 350, Newborn Screening Reauthorization Act Cures 2.0 (not introduced)
Drug Pricing
Filing targets: HOUSE OF REPRESENTATIVES
OVID THERAPEUTICS via THE KPM GROUP DC LLC
2021 · first_quarter · Q1
Pharma M&A
Filing targets: HOUSE OF REPRESENTATIVES
ULTRAGENYX PHARMACEUTICAL via THE KPM GROUP DC LLC
2021 · first_quarter · Q1
H.R. 1730/S. 670, STAT Act H.R. 482/S. 350, Newborn Screening Reauthorization Act H.R. 1916/S.754, Ensuring Lasting Smiles Act Cures 2.0
Drug pricing
Filing targets: HOUSE OF REPRESENTATIVES
MANNKIND CORPORATION via THE KPM GROUP DC LLC
2020 · fourth_quarter · RR
CMS Senior Savings Model and PPE Production through DPA
CMS Senior Savings Model and PPE Production through DPA
SANGAMO THERAPEUTICS, INC via THE KPM GROUP DC LLC
2020 · fourth_quarter · RR
Advancing Access to Precision Medicine Act (not introduced) H.R. 1730/S. 670, STAT Act Cures 2.0 (not introduced) PDUFA VII Reauthorization
Advancing Access to Precision Medicine Act (not introduced) H.R. 1730/S. 670, STAT Act Cures 2.0 (not introduced) PDUFA VII Reauthorization
ORPHAZYME US, INC. via THE KPM GROUP DC LLC
2020 · fourth_quarter · RR
H.R. 1730/S. 670, STAT Act H.R. 482/S. 350, Newborn Screening Reauthorization Act
H.R. 1730/S. 670, STAT Act H.R. 482/S. 350, Newborn Screening Reauthorization Act
CHIESI USA, INC. via THE KPM GROUP DC LLC
2020 · fourth_quarter · Q4
Priority Review Voucher Program; FDA international inspections
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHIESI USA, INC. via THE KPM GROUP DC LLC
2020 · fourth_quarter · RR
Priority Review Voucher Program; FDA international inspections
ZAMBON USA via THE KPM GROUP DC LLC
2020 · fourth_quarter · Q4
S.3868 - Pandemic Care for Burn Pits Exposure Act of 2020
Filing targets: SENATE
OVID THERAPEUTICS via THE KPM GROUP DC LLC
2020 · fourth_quarter · Q4
Priority Review Voucher Program
Filing targets: SENATE
AEGLEA BIOTHERAPEUTICS, INC. via THE KPM GROUP DC LLC
2020 · third_quarter · Q3
H.R.4493 - Federal Employee Short-Term Disability Insurance Act of 2019 S.4010/H.R. 4439 - Creating Hope Reauthorization Act
Drug pricing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALEXION PHARMACEUTICALS via THE KPM GROUP DC LLC
2020 · third_quarter · Q3
S.4010 - Creating Hope Reauthorization Act
Filing targets: SENATE
ZAMBON USA via THE KPM GROUP DC LLC
2020 · third_quarter · Q3
Drug pricing
H.R.4493 - Federal Employee Short-Term Disability Insurance Act of 2019 S.4010/H.R. 4439 - Creating Hope Reauthorization Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OVID THERAPEUTICS via THE KPM GROUP DC LLC
2020 · third_quarter · Q3
H.R.4493 - Federal Employee Short-Term Disability Insurance Act of 2019 S.4010/H.R. 4439 - Creating Hope Reauthorization Act
Drug pricing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ULTRAGENYX PHARMACEUTICAL via THE KPM GROUP DC LLC
2020 · third_quarter · Q3
H.R.4493 - Federal Employee Short-Term Disability Insurance Act of 2019 S.4010/H.R. 4439 - Creating Hope Reauthorization Act
Drug pricing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GRITSTONE ONCOLOGY via THE KPM GROUP DC LLC
2020 · second_quarter · Q2
Biomedical Advanced Research and Development Authority (BARDA) engagement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AEGLEA BIOTHERAPEUTICS, INC. via THE KPM GROUP DC LLC
2020 · second_quarter · Q2
Meetings on Priority Review Vouchers and Biomedical Advanced Research and Development Authority (BARDA) Engagement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUMMIT THERAPEUTICS PLC via THE KPM GROUP DC LLC
2020 · second_quarter · Q2
S.3548/H.R. 748: Coronavirus Aid, Relief, and Economic Security Act or the CARES Act; COVID -19 Stimulus Package (domestic manufacturing)
Filing targets: SENATE
GRITSTONE ONCOLOGY via THE KPM GROUP DC LLC
2020 · second_quarter · RR
Biomedical Advanced Research and Development Authority (BARDA) engagement
AEGLEA BIOTHERAPEUTICS, INC. via THE KPM GROUP DC LLC
2020 · second_quarter · RR
Priority Review Vouchers and Biomedical Advanced Research and Development Authority (BARDA) engagement
SUMMIT THERAPEUTICS PLC via THE KPM GROUP DC LLC
2020 · second_quarter · RR
COVID -19 Stimulus Package (domestic manufacturing)
ZAMBON USA via THE KPM GROUP DC LLC
2020 · second_quarter · Q2
Orphan Drug Tax Credit, Rare/Orphan Drug issues, 21st Century Cures, Coverage Decisions
Filing targets: Centers For Medicare and Medicaid Services (CMS), SENATE
OPIANT PHARMACEUTICALS via THE KPM GROUP DC LLC
2020 · second_quarter · Q2
Opioids/FDA
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALEXION PHARMACEUTICALS via THE KPM GROUP DC LLC
2020 · second_quarter · Q2
Medicare Policy and Reimbursement
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ULTRAGENYX PHARMACEUTICAL via THE KPM GROUP DC LLC
2020 · second_quarter · Q2
New Born Screening Act, Drug Pricing, Priority Review Voucher Program
Filing targets: SENATE, White House Office
ZAMBON USA via THE KPM GROUP DC LLC
2020 · first_quarter · Q1
Orphan Drug Tax Credit, Rare/Orphan Drug issues, 21st Century Cures
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
ULTRAGENYX PHARMACEUTICAL via THE KPM GROUP DC LLC
2020 · first_quarter · Q1
New Born Screening, Orphan Drug Act, FDA
Filing targets: Centers For Medicare and Medicaid Services (CMS), SENATE, White House Office
OPIANT PHARMACEUTICALS via THE KPM GROUP DC LLC
2020 · first_quarter · Q1
Opioids/FDA
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ALEXION PHARMACEUTICALS via THE KPM GROUP DC LLC
2020 · first_quarter · Q1
Medicare Policy and Reimbursement
Filing targets: Centers For Medicare and Medicaid Services (CMS)
ZAMBON USA via THE KPM GROUP DC LLC
2020 · first_quarter · RR
Orphan Drug Tax Credit, Rare/Orphan Drug issues, 21st Century Cures
OVID THERAPEUTICS via THE KPM GROUP DC LLC
2019 · fourth_quarter · Q4
Drug pricing and innovation H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act S.2543 - Prescription Drug Pricing Reduction Act of 2019
Filing targets: SENATE, White House Office
ULTRAGENYX PHARMACEUTICAL via THE KPM GROUP DC LLC
2019 · fourth_quarter · Q4
Drug pricing and innovation H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act S.2543 - Prescription Drug Pricing Reduction Act of 2019
Filing targets: SENATE, White House Office
OVID THERAPEUTICS via THE KPM GROUP DC LLC
2019 · fourth_quarter · RR
Drug pricing and innovation H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act S.2543 - Prescription Drug Pricing Reduction Act of 2019
OPIANT PHARMACEUTICALS via THE KPM GROUP DC LLC
2019 · fourth_quarter · Q4
Opioid epidemic, Fentanyl crisis,and Cannabinoid Overdose
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
ULTRAGENYX PHARMACEUTICAL via THE KPM GROUP DC LLC
2019 · fourth_quarter · RR
Drug Pricing and Innovation H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act S.2543 - Prescription Drug Pricing Reduction Act of 2019
OPIANT PHARMACEUTICALS via THE KPM GROUP DC LLC
2019 · third_quarter · Q3
Opioid epidemic, drug overdose, and national security threat posed by Fentanyl
Filing targets: HOUSE OF REPRESENTATIVES, SENATE